Braeburn Pharmaceuticals files for IPO: Reuters
Braeburn Pharmaceuticals Inc filed with U.S. regulators on Friday to raise up to $150 million in an initial public offering, seven months after its implant to treat opioid addiction was approved in the United States, Reuters reported.
3 January 2017•1 min read
